These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


159 related items for PubMed ID: 8787879

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Expression of glycopeptide-resistance gene in response to vancomycin and teicoplanin in the cardiac vegetations of rabbits infected with VanB-type Enterococcus faecalis.
    Lefort A, Arthur M, Depardieu F, Chau F, Pouzet C, Courvalin P, Fantin B.
    J Infect Dis; 2004 Jan 01; 189(1):90-7. PubMed ID: 14702158
    [Abstract] [Full Text] [Related]

  • 5. Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalis.
    Lafaurie M, Perichon B, Lefort A, Carbon C, Courvalin P, Fantin B.
    Antimicrob Agents Chemother; 2001 Oct 01; 45(10):2826-30. PubMed ID: 11557476
    [Abstract] [Full Text] [Related]

  • 6. Two-step acquisition of resistance to the teicoplanin-gentamicin combination by VanB-type Enterococcus faecalis in vitro and in experimental endocarditis.
    Lefort A, Baptista M, Fantin B, Depardieu F, Arthur M, Carbon C, Courvalin P.
    Antimicrob Agents Chemother; 1999 Mar 01; 43(3):476-82. PubMed ID: 10049254
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
    Ramos MC, Grayson ML, Eliopoulos GM, Bayer AS.
    Antimicrob Agents Chemother; 1992 Sep 01; 36(9):1864-9. PubMed ID: 1329632
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
    Vouillamoz J, Moreillon P, Giddey M, Entenza JM.
    J Antimicrob Chemother; 2006 Dec 01; 58(6):1208-14. PubMed ID: 17030515
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F, Pestel M, Kitzis MD, Lemeland JF, Humbert G, Gutmann L.
    J Infect Dis; 1995 Jan 01; 171(1):106-12. PubMed ID: 7798650
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance.
    Kak V, Donabedian SM, Zervos MJ, Kariyama R, Kumon H, Chow JW.
    Antimicrob Agents Chemother; 2000 Sep 01; 44(9):2545-6. PubMed ID: 10952613
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin.
    Eliopoulos GM, Thauvin-Eliopoulos C, Moellering RC.
    Clin Infect Dis; 1992 Jul 01; 15(1):58-62. PubMed ID: 1319757
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.